Stay informed with the latest litigation news. Explore now

IP Verse

Use Of Landiolol Hydrochloride In The Long-Term Treatment Of Tachyarrhythmias - EP2988750B1

EP2988750

AOP ORPHAN PHARMACEUTICALS
Application Number
EP14720107A
Filing Date
Apr 25, 2014
Status
Granted And Under Opposition
Dec 17, 2021
Grant Date
Jan 19, 2022
External Links
Slate, Register, Google Patents

Bibliography

The patent EP2988750B1 was granted to AOP Orphan Pharmaceuticals on Jan 19, 2022 following the initial filing on Apr 25, 2014 under the application number EP14720107A . The current legal status of the patent is Granted And Under Opposition.

Patent Summary

Patent Family New

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BECKEROct 18, 2022ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents